Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form

被引:61
作者
Anderson, KE
Eliot, LA
Stevenson, BR
Rogers, JA
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
[2] Univ Alberta, Fac Med, Dept Cell Biol & Anat, Edmonton, AB T6G 2N8, Canada
基金
英国医学研究理事会;
关键词
folic acid; liposomes; vancomycin; oral targeted delivery; Caco-2;
D O I
10.1023/A:1011002913601
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To demonstrate utility of folic acid-coated liposomes far enhancing the delivery of a poorly absorbed glycopeptide, vancomycin, via the oral route. Methods. Liposomes prepared as dehydration-rehydration vesicles (DRVs) containing vancomycin were optimized for encapsulation efficiency and stability. A folic acid-poly(ethylene oxide)-cholesterol construct was synthesized for adsorption at DRV surfaces. Liposomes were characterized by differential scanning calorimetry (DSC) and assessed in vitro in the Caco-2 cell model and in vivo in male Sprague-Dawley rats. Non-compartmental pharmacokinetic analysis of vancomycin was conducted after intravenous and oral administration of solution or liposome-encapsulated vancomycin with or without 0.05 mole ratio FA-PEO-Chol adsorbed at liposome surfaces. Results. Optimal loading of vancomycin (32%) was achieved in DRVs of DSPC:Chol:DCP, 3:1:0.25 mole ratio (m.r.) after liposome extrusion. Liposomes released less than 40% of the entrapped drug after 2 hours incubation in simulated gastrointestinal (GI) fluid and simulated intestinal fluid containing a 10 mM bile salt cocktail. Incorporation of FA-PEO-Chol in liposomes increased drug leakage by 20% but resulted in a 5.7-fold increase in Caco-2 cell uptake of vancomycin. Liposomal delivery significantly increased the area under the curve of oral vancomycin resulting in a mean 3.9-fold and 12.5-fold increase in relative bioavailability for uncoated and FA-PEO-Chol-coated liposomes, respectively, compared with an oral solution. Conclusions. The design of FA-PEO-Chol-coated liposomes resulted in a dramatic increase in the oral delivery of a moderate-size glycopeptide in the sat compared with uncoated liposomes or oral solution. It is speculated that the cause of the observed effect was due to binding of liposome surface folic acid to receptors in the GI tract with subsequent receptor-mediated endocytosis of entrapped vancomycin by enterocytes.
引用
收藏
页码:316 / 322
页数:7
相关论文
共 30 条
[1]   Folic acid-PEO-labeled liposomes to improve gastrointestinal absorption of encapsulated agents [J].
Anderson, KE ;
Stevenson, BR ;
Rogers, JA .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :189-198
[2]   POTOCYTOSIS - SEQUESTRATION AND TRANSPORT OF SMALL MOLECULES BY CAVEOLAE [J].
ANDERSON, RGW ;
KAMEN, BA ;
ROTHBERG, KG ;
LACEY, SW .
SCIENCE, 1992, 255 (5043) :410-411
[3]   STABILITY OF LIPOSOMES IN-VITRO AND THEIR UPTAKE BY RAT PEYER PATCHES FOLLOWING ORAL-ADMINISTRATION [J].
ARAMAKI, Y ;
TOMIZAWA, H ;
HARA, T ;
YACHI, K ;
KIKUCHI, H ;
TSUCHIYA, S .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1228-1231
[4]  
BEAHON SJ, 1984, BIOCHEM SOC T, V12, P1088, DOI 10.1042/bst0121088
[5]   Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability [J].
Chen, HM ;
Torchilin, V ;
Langer, R .
JOURNAL OF CONTROLLED RELEASE, 1996, 42 (03) :263-272
[6]   Lectin-bearing polymerized liposomes as potential oral vaccine carriers [J].
Chen, HM ;
Torchilin, V ;
Langer, R .
PHARMACEUTICAL RESEARCH, 1996, 13 (09) :1378-1383
[7]  
CHEUNG RPF, 1986, PHARMACOTHERAPY, V6, P153
[8]  
Cohen Smadar, 1995, Journal of Liposome Research, V5, P813, DOI 10.3109/08982109509012683
[9]  
DIBIASE MD, 1997, PROTEIN DELIVERY PHY, P255
[10]  
Diem K, 1970, DOCUMENTA GEIGY SCI